Results 21 to 30 of about 1,949 (176)
Longitudinal changes in peritoneal solute transport rate and the impact of lower glucose degradation product glucose dialysates. [PDF]
Ther Apher DialAbstract Introduction Peritoneal solute transfer rates (PSTR) are reported to increase with time. Changes in PSTR were reviewed in long‐term peritoneal dialysis (PD) patients to determine whether lower glucose degradation products (low GDP) dialysates prevented an increase in PSTR. Methods PSTR was determined with a 4‐h peritoneal equilibrium test with
Davenport A.
europepmc +2 more sources
Sex Modulates Cardiovascular Effects of Icodextrin-Based Peritoneal Dialysis Solutions
Frontiers in Physiology, 2022 Background/Aims: Some previous observations have noted that after six months of peritoneal dialysis (PD) treatment with icodextrin solutions, blood pressure (BP) and NT-proBNP tend to return to baseline values.
Ramón Paniagua +7 more
doaj +1 more source
Best Evidence Summary for Volume Management of Patients With Heart and Kidney Comorbidity. [PDF]
Nurs OpenABSTRACT Objective To summarise the best evidence of volume management of patients with coexisting cardiac and renal disorders. Design An evidence summary, a form of rapid review. Methods A systematic search was conducted in guideline websites, professional association websites and six databases included Web of Science, Embase, CIHAHL, PubMed, CNKI ...
Aoli H +5 more
europepmc +2 more sources
Biocompatibility of icodextrin [PDF]
Kidney International, 2002 Peritoneal dialysis (PD) has been a successful form of As a result of the growing awareness of the potential chronic renal replacement therapy for more than twenty effects of glucose-based solutions on membrane physiolyears. In spite of the successes of this therapy, there is ogy, there has been an increased emphasis on the devela growing awareness ...
Cooker, Laurinda A. +2 more
openaire +2 more sources
, 2022 Key Points There are important national and center differences in the prescription of icodextrin, with the United States a clear outlier; across all countries, icodextrin was more likely to be used if membrane function tests indicated reduced ...
Davies, Simon
core +2 more sources
Frontiers in Physiology, 2019 Background and objective: During peritoneal dialysis (PD), the period of effective net peritoneal ultrafiltration during long dwells can be extended by using the colloidal osmotic agent icodextrin but there are few detailed studies on ultrafiltration ...
Anna Olszowska +5 more
doaj +1 more source
Case Reports in Nephrology and Dialysis, 2023 In patients treated with peritoneal dialysis (PD), lowering the calcium level in PD fluids results in lower serum calcium levels and higher parathyroid hormone (PTH) levels.
Lara C. Verschuur +4 more
doaj +1 more source
Synthesis and activity of a novel Autotaxin inhibitor-Icodextrin conjugate [PDF]
, 2018 © Copyright 2018 American Chemical Society. Autotaxin is an extracellular phospholipase D that catalyses the hydrolysis of lysophosphatidyl choline (LPC) to generate the bioactive lipid lysophosphatidic acid (LPA).
Ryan Hemming (5635535) +10 more
core +4 more sources
Icodextrin-associated generalized exfoliative skin rash in a CAPD patient: a case-report
BMC Nephrology, 2018 Background Icodextrin is a starch-derived, water soluble glucose polymer, which is used as an alternative to glucose in order to enhance dialytic fluid removal in peritoneal dialysis patients.
Vassilios Liakopoulos +5 more
doaj +1 more source